Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
DOJ
Watson Pharmaceuticals – Now Part of Teva – to Pay $33 Million to…
On January 29, 2018, Mississippi Attorney General Jim Hood announced a $33 million settlement with pharmaceutical manufacturer,…
New Limitations on Guidance Documents Expected to Have Heavy Effect on…
The Trump Administration recently adopted new limits on the use of “guidance documents” issued by federal agencies. Various…
Aegerion Sentenced to Pay $7.2 Million to Patients
On January 30, 2018, Federal U.S. District Court Judge William Young sentenced Aegerion to pay some of the roughly $36 million…
Kmart Settles Whistleblower Case About Inflated Prices
Kmart Corp. has agreed to pay $42 million to the federal government and several states to settle a whistleblower lawsuit…
Founder and Owner of Insys Arrested
Late last week, John N. Kapoor, the founder and majority owner of Insys Therapeutics, Inc., was arrested and charged with leading…
Getting Serious About Fraud – The DOJ Charges 412
With the new administration, there appears to be a renewed commitment to enforcing anti-kickback rules against healthcare…
Aegerion Resolves Criminal and Civil Actions
Aegerion recently finalized a $40.1 million settlement that resolves civil and criminal charges over its marketing of JUXTAPID®.…
AmerisourceBergen Specialty Group Pleads Guilty to Distributing Misbranded…
On September 27, 2017, AmerisourceBergen Specialty Group (ABSG), a wholly-owned subsidiary of AmerisourceBergen Corporation, one…
To Disclose or Not to Disclose… That is the Question: The DOJ’s FCPA Pilot…
It has been over one-year since the US Department of Justice has launched its pilot program aimed to incentivize companies to…
FDA Warns Cipher Over “Misleading” Marketing Materials
The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a warning letter to Cipher…